Login to Your Account



American Society Of Clinical Oncology

Amgen, Abgenix Offer Strong Phase II Panitumumab Results

By Randall Osborne


Wednesday, May 18, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription